Randomized multi-center trial of argatroban with recombinant tissue plasminogen activator for acute stroke (ARTSS-2)

摘要

Background and PurposeWe conducted a randomized exploratory study to assess safety and the probability of a favorable outcome with adjunctive argatroban, a direct thrombin-inhibitor, administered to rt-PA treated ischemic stroke patients.